At a glance
ClinicalIndex Comparison RecordN/ACompleted
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Insulin and Biogenic Amines in Cardiovascular Disease
National Heart, Lung, and Blood Institute (NHLBI)·observational·Posted May 26, 2000·Updated Feb 18, 2016
In Brief
An observational study for Cardiovascular Diseases and 5 related conditions. Completed.
Detailed Summary
To determine the role played by insulin and biogenic amines in obesity-related hypertension and cardiovascular disease.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsCardiovascular Diseases, Hypertension, Heart Diseases, Obesity, Myocardial Infarction, Insulin Resistance
Countries--
Collaborators--
Timeline
N/ACompletedFinished
198619871988198919901991199219931994199519961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartSep 1986
Study CompletionAug 1991
First PostedMay 2000
TodayJul 2026
First PostedMay 26, 2000
Enrollment StartSep 1, 1986
Study CompletionAug 1, 1991
TodayJul 2, 2026
Posted 26.1 years ago